PATENT CLAIM ANALYSIS

Application Number: 16128440
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["424", "181100"]

Abstract:
Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

Claim (Index 10):
The composition of  claim 1 , wherein the at least one 2\u2032 modified nucleotide comprises locked nucleic acid (LNA) or ethylene nucleic acid (ENA).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.65625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14815111', '15381972', '13872052', '13284398', '15995889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7535754207586205
- 35 USC 102 Novelty (BERT): 0.540357515910523
- Combined Prediction Score: 0.7322536302738109
- Mean Citation Score: 258.24367
- Max Citation Score: 269.78894
- Similarity Product: 164.6567742833376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test